Pyridizinone derivatives and the use thereof as H3 inhibitors
US8247414B2 · kind B2 · utility
1Cited by
25References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2007 |
| Grant date | Aug 21, 2012 |
| Priority date | — |
| Expiry date | Nov 18, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel pyridizinone derivatives that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of the histamine H3 receptor, including, for example, neurodegenerative disorders, sleep/wake disorders, attention deficit hyperactivity disorder and cognition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.